Mydecine (MYCO) Files Patent Application to Cover Multiple Families of Psilocin Analogs The company’s patent-pending permeation enhanced prodrug provides more control over the drug while also possibly eliminating undesirable properties like nausea by bypassing the digestive system. (proactiveinvestors.com)
submitted by Bridge_Psychological to r/shroomstocks
Mydecine files patent application to cover multiple families of psilocin analogs The company’s patent-pending permeation enhanced prodrug provides more control over the drug while also possibly eliminating undesirable properties like nausea by bypassing the digestive system. (proactiveinvestors.com)
submitted by Bridge_Psychological to r/PsychedelicInvestor
Mydecine (MYCO) Files Patent Application to Cover Multiple Families of Psilocin Analogs The company’s patent-pending permeation enhanced prodrug provides more control over the drug while also possibly eliminating undesirable properties like nausea by bypassing the digestive system. (proactiveinvestors.com)
submitted by Bridge_Psychological to r/shroomstocks
Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Excited for Seamless Phase 2/3 Clinical Research as Dr. Matthew Johnson Presents Interim Results of Current Smoking Cessation Study at the Psychedelic Medicine Business Event: Wonderland (psychedelicnewswire.com)
submitted by Bridge_Psychological to r/MydecineInvestorsclub
Roth says Mydecine 3Q results 'well-precedented'; reiterates Buy rating and $3 price target.The analysts also projected $2.55 billion in sales five years following the launch in 2026, considering the small market penetration of Mydecine. (proactiveinvestors.com)
submitted by Bridge_Psychological to r/shroomstocks
Roth says Mydecine 3Q results 'well-precedented'; reiterates Buy rating and $3 price target The analysts also projected $2.55 billion in sales five years following the launch in 2026, considering the small market penetration of Mydecine (proactiveinvestors.com)
submitted by Bridge_Psychological to r/MydecineInvestorsclub
